Diagnostic imaging devices are used for the visualization of structural and functional patterns of organs or tissues. Mammography equipment is a type of medical imaging equipment that uses X-rays to capture images (mammograms) of the internal structures of the breasts. GlobalData uses proprietary data and analytics to provide a comprehensive report on the mammography equipment market in New Zealand. Buy the latest report here.
Smarter leaders trust GlobalData
In 2022, GlobalData’s Market Model methodology determined that the leading player in the mammography equipment market in New Zealand was Fujifilm followed by GE HealthCare Technologies, Hologic, Philips Healthcare and Siemens Healthineers.
Understanding market size can be crucial to evaluate opportunities and make informed decisions about market entry and exit. Medical device companies can identify attractive segments in respective markets as well as develop marketing strategies based on forecasts for those segments.
Mammography plays a key role in early diagnosis of breast cancer. 2D digital mammography equipment, breast tomosynthesis and retrofit breast tomosynthesis are covered in this category. Tracked here are the equipment only and not accessories and/or additional costs associated with mammography equipment installation. In 2D Digital Mammography Equipment, X-ray beams are captured on the digital camera and images are produced by the computer, and that images are sent electronically to the radiologists to view. Breast tomosynthesis is a system in which the imaging machines moves around the breast in an arc and taking multiple X-rays that is converted by the computer into 3D images. Retrofit breast tomosynthesis systems are digital panel detectors that enable the upgrade of 2D Digital Mammography Equipment to 3D Digital Mammography Equipment by retrofitting rotating gantry DBT (Digital Breast Tomosynthesis) scanner with a spatially distributed CNT (Carbon Nanotube) X-ray source array.
The mammography equipment market in New Zealand can expand or contract due to a variety of reasons including population demographics, disease incidence and prevalence, macroeconomic issues, and geopolitical considerations. Disruption to a market could be caused by a sudden, unexpected change in these factors, but it could also be driven by changes in clinical practice, leading to a change in diagnosis or treatment of patients, as part of a process to generally improve medical practice.
For the latest analysis of the market size mammography equipment in New Zealand, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.
GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.
